Population
ICU patients with low output syndromes due to cardiac dysfunction, myocardial injury, and inflammatory…
Design
Review
Authors
Loading...
Current inotrope recommendations stand; novel agents remain investigational pending large randomized trials.
This review summarizes the role of inotropes in acute cardiac care, highlighting the guideline-supported use of levosimendan and dobutamine and the potential of novel agents to avoid the mortality risks associated with conventional inotropes.
Parissis et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: